Ligand Pharmaceuticals Director Jason Aryeh Offloads $1.25M in Shares Amid Valuation Concerns and Merger Activity
Jason Aryeh, a director at Ligand Pharmaceuticals Inc (NASDAQ:LGND), executed a series of sales totaling 5,000 shares of common stock valued at approximately $1.25 million. The divestment occurred as the company's shares approached a 52-week high of $258.56, despite the stock appearing overvalued relative to its fair value according to recent analy…